Herti Trastuzumab 440 Mg Injection

Herti Trastuzumab 440 Mg Injection Specification

Dosage Form
Injection

Indication
HER2-positive breast cancer, metastatic gastric cancer

Salt Composition
Trastuzumab

Feature
Monoclonal antibody therapy

Ingredients
Trastuzumab 440 mg/vial

Application
Intravenous administration in hospitals

Physical Color/Texture
White to off-white lyophilized powder

Storage Instructions
Store at 2C to 8C (Refrigerated)

Shelf Life
2 Years

Single Dose Vial
Yes

Packaging Type
Box

Needs Reconstitution
Yes

Brand Name
Herti

Usage
Hospital

Solvent Provided
Yes

Packaging Size
20ml

Manufactured By
HETERO HEALTHCARE

No Enzyme Activity
Yes

For IV Use Only
Yes

Her2 Targeted Therapy
Yes

Prescription Required
Yes

Strength
440 mg

Herti Trastuzumab 440 Mg Injection Trade Information

Minimum Order Quantity
1 Vial

Supply Ability
5000 Vials Per Month

Delivery Time
10 Days

About Herti Trastuzumab 440 Mg Injection

Discover the incomparable Herti Trastuzumab 440 Mg Injection-where flawless quality meets unbeatable value! Take advantage of our exclusive price cut and grab this splendiferous bargain for hospital use. Manufactured by HETERO HEALTHCARE, this discounted, high-strength monoclonal antibody therapy targets HER2-positive breast and metastatic gastric cancers. Herti is a single-dose vial provided with solvent, precisely formulated for IV administration. This well-packaged, prescription-only solution requires reconstitution and boasts a shelf life of two years. Experience trustworthy distribution from an exporter, supplier, trader, and wholesaler in India. Elevate your hospital's care with Herti!

Versatile Hospital Use and Targeted Therapy

Herti Trastuzumab 440 Mg Injection is specifically designed for hospital usage, offering effective HER2-targeted therapy for patients with HER2-positive breast cancer and metastatic gastric cancer. This splendiferous injectable solution, with its white to off-white lyophilized powder, is administered intravenously by healthcare professionals and is intended for single-dose applications. Stored at 2C to 8C, Herti is ideal for controlled medical environments seeking uncompromised quality and reliability in their cancer treatment protocols.

Certified Packaging and Swift Delivery Process

Each order of Herti Trastuzumab 440 Mg Injection is meticulously packaged in a 20ml box to ensure product integrity during transit. With reputable certifications backing its manufacturing and distribution, this product is delivered with precision after prompt order processing. Expect efficient handling and professional care at every stage- from charging your order to ensuring it is delivered quickly and safely. Your hospital trust deserves Herti's impeccable standards and commitment to quality assurance.

FAQ's of Herti Trastuzumab 440 Mg Injection:

Q: How should Herti Trastuzumab 440 Mg Injection be administered in a hospital setting?

A: Herti Trastuzumab 440 Mg Injection should be administered intravenously by qualified healthcare professionals in a hospital. It is intended for single-dose use and must be reconstituted with the provided solvent prior to IV administration.

Q: What are the indications for using Herti Trastuzumab 440 Mg Injection?

A: Herti Trastuzumab is indicated for the treatment of HER2-positive breast cancer and metastatic gastric cancer, offering targeted monoclonal antibody therapy for eligible patients.

Q: When will my order for Herti Trastuzumab be processed and delivered?

A: Once your order is placed, the processing begins promptly. The injection is packaged securely and delivered within the stipulated timeline, ensuring safe and timely arrival to your medical facility.

Q: Where should Herti Trastuzumab 440 Mg Injection be stored before use?

A: This medication should be kept refrigerated, stored at temperatures between 2C and 8C, to maintain its efficacy throughout the two-year shelf life.

Q: What certifications support the quality of Herti Trastuzumab 440 Mg Injection?

A: Herti Trastuzumab is manufactured under reputable certifications, ensuring adherence to stringent safety, quality, and medical standards for hospital usage.

Q: How does Herti Trastuzumab benefit patients with HER2-positive cancers?

A: Herti Trastuzumab delivers targeted therapy against HER2-positive cancer cells, providing effective and tailored treatment, which can help improve patient outcomes.

Tell us about your requirement